Adalimumab Treatment in Pediatric-Onset Crohn's Disease Patients after Infliximab Failure: A Single Center Study

PURPOSE: We aimed to investigate the efficacy and safety of adalimumab in pediatric-onset Crohn's disease patients who had failed treatment with infliximab. METHODS: In this retrospective study, patients included were those who had been diagnosed with Crohn's disease before 18 years old, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Won Jae, Kang, Ben, Choi, So Yoon, Choe, Yon Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942309/
https://www.ncbi.nlm.nih.gov/pubmed/27437188
http://dx.doi.org/10.5223/pghn.2016.19.2.116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942309/
https://www.ncbi.nlm.nih.gov/pubmed/27437188
http://dx.doi.org/10.5223/pghn.2016.19.2.116

Ejemplares similares